nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—Testosterone—Prednisolone—ankylosing spondylitis	0.372	1	CrCrCtD
Abiraterone—CYP17A1—Dexamethasone—ankylosing spondylitis	0.23	0.42	CbGbCtD
Abiraterone—ABCC1—Methotrexate—ankylosing spondylitis	0.063	0.115	CbGbCtD
Abiraterone—ALB—Prednisone—ankylosing spondylitis	0.0579	0.106	CbGbCtD
Abiraterone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0299	0.0549	CbGbCtD
Abiraterone—ALB—Methotrexate—ankylosing spondylitis	0.029	0.0532	CbGbCtD
Abiraterone—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0279	0.0512	CbGbCtD
Abiraterone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0227	0.0416	CbGbCtD
Abiraterone—CYP3A4—Betamethasone—ankylosing spondylitis	0.0195	0.0357	CbGbCtD
Abiraterone—CYP3A4—Prednisolone—ankylosing spondylitis	0.0192	0.0352	CbGbCtD
Abiraterone—CYP3A4—Prednisone—ankylosing spondylitis	0.0181	0.0332	CbGbCtD
Abiraterone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0178	0.0326	CbGbCtD
Abiraterone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0113	0.0207	CbGbCtD
Abiraterone—Blood potassium decreased—Methylprednisolone—ankylosing spondylitis	0.00213	0.0259	CcSEcCtD
Abiraterone—Blood potassium decreased—Prednisone—ankylosing spondylitis	0.00169	0.0205	CcSEcCtD
Abiraterone—Hypernatraemia—Prednisolone—ankylosing spondylitis	0.00168	0.0204	CcSEcCtD
Abiraterone—Hypernatraemia—Triamcinolone—ankylosing spondylitis	0.00154	0.0188	CcSEcCtD
Abiraterone—Hypernatraemia—Methylprednisolone—ankylosing spondylitis	0.00154	0.0187	CcSEcCtD
Abiraterone—Hypernatraemia—Betamethasone—ankylosing spondylitis	0.0014	0.017	CcSEcCtD
Abiraterone—Hypernatraemia—Dexamethasone—ankylosing spondylitis	0.0014	0.017	CcSEcCtD
Abiraterone—Multiple fractures—Methylprednisolone—ankylosing spondylitis	0.00139	0.0169	CcSEcCtD
Abiraterone—Fracture—Methylprednisolone—ankylosing spondylitis	0.00139	0.0169	CcSEcCtD
Abiraterone—Fracture—Betamethasone—ankylosing spondylitis	0.00127	0.0154	CcSEcCtD
Abiraterone—Multiple fractures—Betamethasone—ankylosing spondylitis	0.00127	0.0154	CcSEcCtD
Abiraterone—Multiple fractures—Dexamethasone—ankylosing spondylitis	0.00127	0.0154	CcSEcCtD
Abiraterone—Fracture—Dexamethasone—ankylosing spondylitis	0.00127	0.0154	CcSEcCtD
Abiraterone—Lymphopenia—Prednisone—ankylosing spondylitis	0.00125	0.0152	CcSEcCtD
Abiraterone—Hypernatraemia—Prednisone—ankylosing spondylitis	0.00122	0.0148	CcSEcCtD
Abiraterone—Hypertriglyceridaemia—Prednisone—ankylosing spondylitis	0.00112	0.0136	CcSEcCtD
Abiraterone—Multiple fractures—Prednisone—ankylosing spondylitis	0.0011	0.0134	CcSEcCtD
Abiraterone—Fracture—Prednisone—ankylosing spondylitis	0.0011	0.0134	CcSEcCtD
Abiraterone—Sudden death—Methotrexate—ankylosing spondylitis	0.00105	0.0127	CcSEcCtD
Abiraterone—Blood triglycerides increased—Prednisone—ankylosing spondylitis	0.000979	0.0119	CcSEcCtD
Abiraterone—Multiple fractures—Methotrexate—ankylosing spondylitis	0.000923	0.0112	CcSEcCtD
Abiraterone—Fracture—Methotrexate—ankylosing spondylitis	0.000923	0.0112	CcSEcCtD
Abiraterone—Contusion—Dexamethasone—ankylosing spondylitis	0.000845	0.0103	CcSEcCtD
Abiraterone—Contusion—Betamethasone—ankylosing spondylitis	0.000845	0.0103	CcSEcCtD
Abiraterone—Fluid retention—Prednisolone—ankylosing spondylitis	0.000838	0.0102	CcSEcCtD
Abiraterone—Fluid retention—Triamcinolone—ankylosing spondylitis	0.000771	0.00936	CcSEcCtD
Abiraterone—Fluid retention—Methylprednisolone—ankylosing spondylitis	0.000769	0.00934	CcSEcCtD
Abiraterone—Contusion—Prednisone—ankylosing spondylitis	0.000735	0.00893	CcSEcCtD
Abiraterone—Fluid retention—Dexamethasone—ankylosing spondylitis	0.0007	0.0085	CcSEcCtD
Abiraterone—Fluid retention—Betamethasone—ankylosing spondylitis	0.0007	0.0085	CcSEcCtD
Abiraterone—Hepatotoxicity—Methotrexate—ankylosing spondylitis	0.000694	0.00844	CcSEcCtD
Abiraterone—Hypercholesterolaemia—Prednisone—ankylosing spondylitis	0.000678	0.00824	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.000676	0.00821	CcSEcCtD
Abiraterone—Fluid retention—Prednisone—ankylosing spondylitis	0.000609	0.0074	CcSEcCtD
Abiraterone—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.000603	0.00732	CcSEcCtD
Abiraterone—Cardiac failure—Betamethasone—ankylosing spondylitis	0.000548	0.00666	CcSEcCtD
Abiraterone—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.000548	0.00666	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.000519	0.0063	CcSEcCtD
Abiraterone—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.000487	0.00591	CcSEcCtD
Abiraterone—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.000487	0.00591	CcSEcCtD
Abiraterone—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.000487	0.00591	CcSEcCtD
Abiraterone—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.000484	0.00588	CcSEcCtD
Abiraterone—Cardiac failure—Prednisone—ankylosing spondylitis	0.000477	0.0058	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.000474	0.00575	CcSEcCtD
Abiraterone—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000453	0.00551	CcSEcCtD
Abiraterone—Infestation—Methylprednisolone—ankylosing spondylitis	0.000453	0.00551	CcSEcCtD
Abiraterone—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.000448	0.00544	CcSEcCtD
Abiraterone—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.000447	0.00543	CcSEcCtD
Abiraterone—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.000445	0.00541	CcSEcCtD
Abiraterone—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.000444	0.0054	CcSEcCtD
Abiraterone—Hypokalaemia—Prednisone—ankylosing spondylitis	0.000424	0.00515	CcSEcCtD
Abiraterone—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000417	0.00507	CcSEcCtD
Abiraterone—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000417	0.00507	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.000411	0.00499	CcSEcCtD
Abiraterone—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000406	0.00494	CcSEcCtD
Abiraterone—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000406	0.00494	CcSEcCtD
Abiraterone—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000404	0.00491	CcSEcCtD
Abiraterone—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000404	0.00491	CcSEcCtD
Abiraterone—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.0004	0.00486	CcSEcCtD
Abiraterone—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000396	0.00481	CcSEcCtD
Abiraterone—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000378	0.00459	CcSEcCtD
Abiraterone—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000369	0.00448	CcSEcCtD
Abiraterone—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000367	0.00445	CcSEcCtD
Abiraterone—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000364	0.00442	CcSEcCtD
Abiraterone—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000363	0.00442	CcSEcCtD
Abiraterone—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000363	0.00441	CcSEcCtD
Abiraterone—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000356	0.00433	CcSEcCtD
Abiraterone—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000354	0.0043	CcSEcCtD
Abiraterone—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000352	0.00427	CcSEcCtD
Abiraterone—Angiopathy—Betamethasone—ankylosing spondylitis	0.000336	0.00408	CcSEcCtD
Abiraterone—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000336	0.00408	CcSEcCtD
Abiraterone—Hypertension—Prednisolone—ankylosing spondylitis	0.000333	0.00405	CcSEcCtD
Abiraterone—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000331	0.00402	CcSEcCtD
Abiraterone—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000331	0.00402	CcSEcCtD
Abiraterone—Discomfort—Prednisolone—ankylosing spondylitis	0.000325	0.00394	CcSEcCtD
Abiraterone—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000317	0.00385	CcSEcCtD
Abiraterone—Oedema—Prednisolone—ankylosing spondylitis	0.000315	0.00383	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000313	0.0038	CcSEcCtD
Abiraterone—Cough—Triamcinolone—ankylosing spondylitis	0.00031	0.00376	CcSEcCtD
Abiraterone—Hypertension—Triamcinolone—ankylosing spondylitis	0.000306	0.00372	CcSEcCtD
Abiraterone—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000306	0.00371	CcSEcCtD
Abiraterone—Myalgia—Triamcinolone—ankylosing spondylitis	0.000302	0.00367	CcSEcCtD
Abiraterone—Pneumonia—Methotrexate—ankylosing spondylitis	0.000302	0.00367	CcSEcCtD
Abiraterone—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000302	0.00366	CcSEcCtD
Abiraterone—Infestation NOS—Methotrexate—ankylosing spondylitis	0.0003	0.00364	CcSEcCtD
Abiraterone—Infestation—Methotrexate—ankylosing spondylitis	0.0003	0.00364	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000299	0.00364	CcSEcCtD
Abiraterone—Discomfort—Triamcinolone—ankylosing spondylitis	0.000299	0.00363	CcSEcCtD
Abiraterone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000298	0.00362	CcSEcCtD
Abiraterone—Angiopathy—Prednisone—ankylosing spondylitis	0.000292	0.00355	CcSEcCtD
Abiraterone—Oedema—Triamcinolone—ankylosing spondylitis	0.00029	0.00352	CcSEcCtD
Abiraterone—Arrhythmia—Prednisone—ankylosing spondylitis	0.000288	0.0035	CcSEcCtD
Abiraterone—Infection—Triamcinolone—ankylosing spondylitis	0.000288	0.0035	CcSEcCtD
Abiraterone—Infection—Methylprednisolone—ankylosing spondylitis	0.000287	0.00349	CcSEcCtD
Abiraterone—Haematuria—Methotrexate—ankylosing spondylitis	0.000286	0.00347	CcSEcCtD
Abiraterone—Insomnia—Prednisolone—ankylosing spondylitis	0.000285	0.00346	CcSEcCtD
Abiraterone—Mental disorder—Prednisone—ankylosing spondylitis	0.000282	0.00343	CcSEcCtD
Abiraterone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000281	0.00341	CcSEcCtD
Abiraterone—Hypertension—Betamethasone—ankylosing spondylitis	0.000278	0.00338	CcSEcCtD
Abiraterone—Hypertension—Dexamethasone—ankylosing spondylitis	0.000278	0.00338	CcSEcCtD
Abiraterone—Myalgia—Dexamethasone—ankylosing spondylitis	0.000274	0.00333	CcSEcCtD
Abiraterone—Myalgia—Betamethasone—ankylosing spondylitis	0.000274	0.00333	CcSEcCtD
Abiraterone—Discomfort—Dexamethasone—ankylosing spondylitis	0.000271	0.00329	CcSEcCtD
Abiraterone—Discomfort—Betamethasone—ankylosing spondylitis	0.000271	0.00329	CcSEcCtD
Abiraterone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000266	0.00323	CcSEcCtD
Abiraterone—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000264	0.00321	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000264	0.00321	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000263	0.0032	CcSEcCtD
Abiraterone—Oedema—Betamethasone—ankylosing spondylitis	0.000263	0.00319	CcSEcCtD
Abiraterone—Oedema—Dexamethasone—ankylosing spondylitis	0.000263	0.00319	CcSEcCtD
Abiraterone—Insomnia—Triamcinolone—ankylosing spondylitis	0.000262	0.00318	CcSEcCtD
Abiraterone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000261	0.00318	CcSEcCtD
Abiraterone—Infection—Betamethasone—ankylosing spondylitis	0.000261	0.00317	CcSEcCtD
Abiraterone—Infection—Dexamethasone—ankylosing spondylitis	0.000261	0.00317	CcSEcCtD
Abiraterone—Anaemia—Prednisone—ankylosing spondylitis	0.000259	0.00315	CcSEcCtD
Abiraterone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000258	0.00314	CcSEcCtD
Abiraterone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000255	0.0031	CcSEcCtD
Abiraterone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000254	0.00309	CcSEcCtD
Abiraterone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00025	0.00304	CcSEcCtD
Abiraterone—Fatigue—Triamcinolone—ankylosing spondylitis	0.00025	0.00303	CcSEcCtD
Abiraterone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000249	0.00303	CcSEcCtD
Abiraterone—Angiopathy—Methotrexate—ankylosing spondylitis	0.000244	0.00297	CcSEcCtD
Abiraterone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000243	0.00295	CcSEcCtD
Abiraterone—Hypertension—Prednisone—ankylosing spondylitis	0.000242	0.00294	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00024	0.00291	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00024	0.00291	CcSEcCtD
Abiraterone—Myalgia—Prednisone—ankylosing spondylitis	0.000239	0.0029	CcSEcCtD
Abiraterone—Insomnia—Betamethasone—ankylosing spondylitis	0.000238	0.00289	CcSEcCtD
Abiraterone—Insomnia—Dexamethasone—ankylosing spondylitis	0.000238	0.00289	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000237	0.00288	CcSEcCtD
Abiraterone—Discomfort—Prednisone—ankylosing spondylitis	0.000236	0.00287	CcSEcCtD
Abiraterone—Mental disorder—Methotrexate—ankylosing spondylitis	0.000236	0.00287	CcSEcCtD
Abiraterone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000231	0.00281	CcSEcCtD
Abiraterone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000231	0.00281	CcSEcCtD
Abiraterone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000229	0.00278	CcSEcCtD
Abiraterone—Oedema—Prednisone—ankylosing spondylitis	0.000229	0.00278	CcSEcCtD
Abiraterone—Infection—Prednisone—ankylosing spondylitis	0.000227	0.00276	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000227	0.00276	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000227	0.00276	CcSEcCtD
Abiraterone—Fatigue—Betamethasone—ankylosing spondylitis	0.000227	0.00275	CcSEcCtD
Abiraterone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000227	0.00275	CcSEcCtD
Abiraterone—Skin disorder—Prednisone—ankylosing spondylitis	0.000222	0.0027	CcSEcCtD
Abiraterone—Anaemia—Methotrexate—ankylosing spondylitis	0.000217	0.00263	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000209	0.00253	CcSEcCtD
Abiraterone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000208	0.00252	CcSEcCtD
Abiraterone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000208	0.00252	CcSEcCtD
Abiraterone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000208	0.00252	CcSEcCtD
Abiraterone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000207	0.00252	CcSEcCtD
Abiraterone—Insomnia—Prednisone—ankylosing spondylitis	0.000207	0.00252	CcSEcCtD
Abiraterone—Cough—Methotrexate—ankylosing spondylitis	0.000205	0.00248	CcSEcCtD
Abiraterone—Dyspepsia—Prednisone—ankylosing spondylitis	0.000202	0.00245	CcSEcCtD
Abiraterone—Chest pain—Methotrexate—ankylosing spondylitis	0.0002	0.00242	CcSEcCtD
Abiraterone—Myalgia—Methotrexate—ankylosing spondylitis	0.0002	0.00242	CcSEcCtD
Abiraterone—Rash—Prednisolone—ankylosing spondylitis	0.000199	0.00241	CcSEcCtD
Abiraterone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000198	0.00241	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000198	0.00241	CcSEcCtD
Abiraterone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000198	0.0024	CcSEcCtD
Abiraterone—Fatigue—Prednisone—ankylosing spondylitis	0.000197	0.0024	CcSEcCtD
Abiraterone—Discomfort—Methotrexate—ankylosing spondylitis	0.000197	0.0024	CcSEcCtD
Abiraterone—Constipation—Prednisone—ankylosing spondylitis	0.000196	0.00238	CcSEcCtD
Abiraterone—Infection—Methotrexate—ankylosing spondylitis	0.00019	0.00231	CcSEcCtD
Abiraterone—Asthenia—Dexamethasone—ankylosing spondylitis	0.000189	0.00229	CcSEcCtD
Abiraterone—Asthenia—Betamethasone—ankylosing spondylitis	0.000189	0.00229	CcSEcCtD
Abiraterone—Skin disorder—Methotrexate—ankylosing spondylitis	0.000186	0.00226	CcSEcCtD
Abiraterone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000184	0.00224	CcSEcCtD
Abiraterone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000184	0.00223	CcSEcCtD
Abiraterone—Rash—Triamcinolone—ankylosing spondylitis	0.000183	0.00222	CcSEcCtD
Abiraterone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000183	0.00222	CcSEcCtD
Abiraterone—Rash—Methylprednisolone—ankylosing spondylitis	0.000182	0.00221	CcSEcCtD
Abiraterone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000182	0.00221	CcSEcCtD
Abiraterone—Body temperature increased—Prednisone—ankylosing spondylitis	0.000181	0.0022	CcSEcCtD
Abiraterone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00018	0.00218	CcSEcCtD
Abiraterone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00018	0.00218	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000174	0.00212	CcSEcCtD
Abiraterone—Insomnia—Methotrexate—ankylosing spondylitis	0.000173	0.0021	CcSEcCtD
Abiraterone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000171	0.00207	CcSEcCtD
Abiraterone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000168	0.00205	CcSEcCtD
Abiraterone—Vomiting—Betamethasone—ankylosing spondylitis	0.000167	0.00203	CcSEcCtD
Abiraterone—Vomiting—Dexamethasone—ankylosing spondylitis	0.000167	0.00203	CcSEcCtD
Abiraterone—Rash—Dexamethasone—ankylosing spondylitis	0.000166	0.00201	CcSEcCtD
Abiraterone—Rash—Betamethasone—ankylosing spondylitis	0.000166	0.00201	CcSEcCtD
Abiraterone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000166	0.00201	CcSEcCtD
Abiraterone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000166	0.00201	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000165	0.00201	CcSEcCtD
Abiraterone—Fatigue—Methotrexate—ankylosing spondylitis	0.000165	0.002	CcSEcCtD
Abiraterone—Asthenia—Prednisone—ankylosing spondylitis	0.000164	0.002	CcSEcCtD
Abiraterone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000157	0.0019	CcSEcCtD
Abiraterone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000151	0.00184	CcSEcCtD
Abiraterone—Vomiting—Prednisone—ankylosing spondylitis	0.000146	0.00177	CcSEcCtD
Abiraterone—Rash—Prednisone—ankylosing spondylitis	0.000144	0.00175	CcSEcCtD
Abiraterone—Dermatitis—Prednisone—ankylosing spondylitis	0.000144	0.00175	CcSEcCtD
Abiraterone—Asthenia—Methotrexate—ankylosing spondylitis	0.000137	0.00167	CcSEcCtD
Abiraterone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000131	0.00159	CcSEcCtD
Abiraterone—Vomiting—Methotrexate—ankylosing spondylitis	0.000122	0.00148	CcSEcCtD
Abiraterone—Rash—Methotrexate—ankylosing spondylitis	0.000121	0.00147	CcSEcCtD
Abiraterone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000121	0.00146	CcSEcCtD
